| [1] |
Mizrahi J, Pant S. Immunotherapy in Gastrointestinal Malignancies[J]. Adv Exp Med Biol, 2020, 1244:93-106.
doi: 10.1007/978-3-030-41008-7_5
pmid: 32301012
|
| [2] |
王昱欢, 吴穹, 马晓峰, 等. 氧化三甲胺在动脉粥样硬化中的研究进展[J]. 中国动脉硬化杂志, 2023, 31(10):901-908.
|
| [3] |
Li CY, Chen XL, Zhang D, et al. Structural mechanism for bacterial oxidation of oceanic trimethylamine into trimethylamine N-oxide[J]. Mol Microbiol, 2017, 103(6):992-1003.
|
| [4] |
刘恺闻, 张魁, 周宁, 等. 肠道菌群与冠心病关系的研究进展[J]. 中国胸心血管外科临床杂志, 2023, 30(5):746-752.
|
| [5] |
Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health[J]. EXCLI J, 2021, 20:301-319.
doi: 10.17179/excli2020-3239
pmid: 33746664
|
| [6] |
Fennema D, Phillips IR, Shephard EA. Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease[J]. Drug Metab Dispos, 2016, 44(11):1839-1850.
pmid: 27190056
|
| [7] |
Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide[J]. APMIS, 2020, 128(5):353-366.
doi: 10.1111/apm.13038
pmid: 32108960
|
| [8] |
宫铭, 张成普. 氧化三甲胺与老年常见恶性肿瘤关系的研究进展[J]. 实用老年医学, 2022, 36(1):14-18.
|
| [9] |
敦泽, 郭立芳. 幽门螺杆菌致病机制的研究进展[J]. 中国中西医结合消化杂志, 2020, 28(8):645-648.
|
| [10] |
Tacconi E, Palma G, De Biase D, et al. Microbiota effect on trimethylamine N-Oxide production: From Cancer to Fitness-a practical preventing recommendation and therapies[J]. Nutrients, 2023, 15(3):563.
|
| [11] |
Stonans I, Kuzmina J, Polaka I, et al. The association of circulating L-carnitine, gamma-butyrobetaine and trimethylamine N-oxide levels with gastric cancer[J]. Diagnostics (Basel), 2023, 13(7):1341.
|
| [12] |
Jalandra R, Dalal N, Yadav AK, et al. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer[J]. Appl Microbiol Biotechnol, 2021, 105(20):7651-7660.
|
| [13] |
Bardel̆cíková A, Šoltys J, Mojžiš J. Oxidative stress, inflammation and colorectal cancer: An overview[J]. Antioxidants (Basel), 2023, 12(4):901.
|
| [14] |
Yue C, Yang X, Li J, et al. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells[J]. Biochem Biophys Res Commun, 2017, 490(2):541-551.
|
| [15] |
Ke Y, Li D, Zhao M, et al. Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress[J]. Free Radic Biol Med, 2018, 116:88-100.
|
| [16] |
Man A, Zhou Y, Xia N, et al. Involvement of gut microbiota, microbial metabolites and interaction with polyphenol in host immunometabolism[J]. Nutrients, 2020, 12(10):3054.
|
| [17] |
Tarashi S, Siadat SD, Ahmadi BS, et al. Gut Bacteria and their metabolites: Which one is the defendant for colorectal cancer?[J]. Microorganisms, 2019, 7(11):561.
|
| [18] |
Drapala A, Szudzik M, Chabowski D, et al. Heart failure disturbs gut-blood barrier and increases plasma trimethylamine, a toxic bacterial metabolite[J]. Int J Mol Sci, 2020, 21(17):6161.
|
| [19] |
Sanchez-Alcoholado L, Ordonez R, Otero A, et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer[J]. Int J Mol Sci, 2020, 21(18):6782.
|
| [20] |
Yang S, Dai H, Lu Y, et al. Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer[J]. J Immunol Res, 2022, 2022:7043856.
|
| [21] |
Bhat MY, Singh LR, Dar TA. Trimethylamine N-oxide abolishes the chaperone activity of alpha-casein: An intrinsically disordered protein[J]. Sci Rep, 2017, 7(1):6572.
|
| [22] |
刘燕娥. 肠道菌群和氧化三甲胺与原发性肝癌的关系研究[D]. 长春: 吉林大学, 2023.
|
| [23] |
Cox IJ, Aliev AE, Crossey MM, et al. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study[J]. World J Gastroenterol, 2016, 22(16):4191-4200.
|
| [24] |
Yang S, Li X, Yang F, et al. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target[J]. Front Pharmacol, 2019, 10:1360.
doi: 10.3389/fphar.2019.01360
pmid: 31803054
|
| [25] |
Huang JY, Luu HN, Butler LM, et al. A prospective evaluation of serum methionine-related metabolites in relation to pancreatic cancer risk in two prospective cohort studies[J]. Int J Cancer, 2020, 147(7):1917-1927.
doi: 10.1002/ijc.32994
pmid: 32222976
|
| [26] |
Mirji G, Worth A, Bhat SA, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer[J]. Sci Immunol, 2022, 7(75):eabn704.
|
), 王学红2, 绽永华2, 安琪2, 张宏琳2
